Roche @Roche · 28 Aug 2026
#MEDIA – At #APVRS2026, we're pleased to share new two-year data for our treatment in patients with PCV, a severe sub-type of nAMD – the leading cause of vision loss in people over 60. https://t.co/9XpS4N4WXT https://t.co/0pB6w4ulTo
3 120Views
9Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
8.22×vs this author's median380 views is typical
75Percentile for this authorof 12 recent posts
0.53×vs 100K–1M median5 930 views is typical
1.31%Reachviews ÷ followers
0.29%Engagement rateof viewers reacted